These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5388239)

  • 21. [Plasma coagulation tests. Phase 3].
    Abe T
    Rinsho Byori; 1969; 16():Suppl 16:93+. PubMed ID: 5391590
    [No Abstract]   [Full Text] [Related]  

  • 22. ISOLATION AND PROPERTIES OF ANTICOAGULANTS FROM FIBRINOLYSED AND HUMAN HEART-PUMP PLASMAS.
    TRIANTAPHYLLOPOULOS DC; TRIANTAPHYLLOPOULOS E
    Can J Physiol Pharmacol; 1964 Mar; 42():169-87. PubMed ID: 14329312
    [No Abstract]   [Full Text] [Related]  

  • 23. Factor analysis of the normal electrocardiogram. 2. With special reference to the second-order factors.
    Moritani S; Ota G
    Jpn Circ J; 1973 Jun; 37(6):619-32. PubMed ID: 4270648
    [No Abstract]   [Full Text] [Related]  

  • 24. Antithrombin III. Theory and clinical applications. H. P. Smith Memorial Lecture.
    Seegers WH
    Am J Clin Pathol; 1978 Apr; 69(4):299-359. PubMed ID: 347919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Standardization of the laboratory method for antithrombin activity measurement].
    Okajima K
    Rinsho Byori; 2002 Mar; 50(3):283-6. PubMed ID: 11985057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Behavior of thrombin time, activities of antithrombin II and 3 following administration of cobalt (II) compounds in rabbits].
    Wohllebe W; Taube C; Fiedler H
    Z Gesamte Inn Med; 1968 Sep; 23(17):537-9. PubMed ID: 5715725
    [No Abstract]   [Full Text] [Related]  

  • 27. On the nature of antithrombin V.
    Vinazzer H; Reinhardt F
    Thromb Diath Haemorrh; 1968 Nov; 20(1):234-46. PubMed ID: 5708894
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of new methods for studies of blood coagulation. II. Clot-sedimentation-technic for the determination of antithrombin I effect of fibrin].
    Dolesobel W
    Wien Med Wochenschr; 1972 Oct; 122(41):585-90. PubMed ID: 4628353
    [No Abstract]   [Full Text] [Related]  

  • 29. [Efficiency and limits of blood coagulation tests].
    Róka L
    Internist (Berl); 1973 Apr; 14(4):149-53. PubMed ID: 4577209
    [No Abstract]   [Full Text] [Related]  

  • 30. Uptake of heparin cofactor II and antithrombin into the aorta wall after a deendothelializing injury in vivo: comparison with the behaviors of prothrombin and fibrinogen.
    Hatton MW; Ross B; Southward SM; Dereske M; Hoogendoorn H; Blajchman MA; Richardson M
    J Lab Clin Med; 1999 Jan; 133(1):81-7. PubMed ID: 10385486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings: Platelet survival, fibrinolytic activity, antithrombin II (AT III) level and fibrinogen survival in venous thromboembolism (VTE).
    Gallus AS; Walker IR; Hirsh J; Halasah G; Evans G
    Thromb Diath Haemorrh; 1975 Nov; 34(2):566. PubMed ID: 1198447
    [No Abstract]   [Full Text] [Related]  

  • 33. Implications of depressed antithrombin-3 activity associated with oral contraceptives.
    Zuck TF; Bergin JJ; Raymond JM; Dwyre WR
    Surg Gynecol Obstet; 1971 Oct; 133(4):609-12. PubMed ID: 5096309
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-thormbin III and heparin clotting times in thrombosis and atherosclerosis.
    O'Brien JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):116-23. PubMed ID: 4454034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of fibrinogen on the aggregation of washed human blood platelets induced by adenosine diphosphate, thrombin, collagen, and adrenaline.
    Solum NO; Stormorken H
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:170+. PubMed ID: 5862557
    [No Abstract]   [Full Text] [Related]  

  • 37. THE INFLUENCE OF INORGANIC SALTS ON PLASMA ANTITHROMBIN ACTIVITY.
    MONKHOUSE FC
    Thromb Diath Haemorrh; 1963 Jul; 143():387-94. PubMed ID: 14081261
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnostic of blood coagulation].
    Barthels M
    Hamostaseologie; 2008 Dec; 28(5):320-34. PubMed ID: 19132163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formation of anticoagulants by digesting fibrin with thrombin.
    Triantaphyllopoulos DC; Muirhead CR
    Thromb Diath Haemorrh; 1968 Jul; 19(3):397-402. PubMed ID: 5304346
    [No Abstract]   [Full Text] [Related]  

  • 40. The reversible antithrombin activity of incubated plasma.
    Gomperts ED; Stavridis JC; Mibashan RS
    Thromb Haemost; 1977 Feb; 37(1):123-35. PubMed ID: 65800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.